Anupam Rasayan India Ltd. (IN:ANURAS)
:ANURAS
Top Page
Anupam Rasayan India Ltd.
(ANURAS)
Select Model
Select Model
Rating:64Neutral
Price Target:
₹1,336.00
▲(0.63% Upside)
Action:ReiteratedDate:11/22/25
The overall score of 64 for Anupam Rasayan India Ltd. is primarily driven by strong technical momentum (score: 85) indicating bullish price trends. However, this is tempered by mixed financial performance (score: 58) with significant cash flow concerns and a high P/E ratio in valuation (score: 45) suggesting potential overvaluation. Investors should weigh the positive technicals against financial and valuation risks.
Positive Factors
Revenue Growth
Strong revenue growth indicates robust demand for Anupam Rasayan's specialty chemicals, supporting long-term business expansion and market penetration.
Negative Factors
Profitability Challenges
Decreasing net profit margins highlight potential cost management issues, which could affect long-term profitability if not addressed.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue Growth
Strong revenue growth indicates robust demand for Anupam Rasayan's specialty chemicals, supporting long-term business expansion and market penetration.
Read all positive factors
Anupam Rasayan India Ltd. (ANURAS) vs. iShares MSCI India ETF (INDA)
Market Cap
₹142.09B
Dividend Yield0.06%
Average Volume (3M)7.28K
Price to Earnings (P/E)76.5
Beta (1Y)0.66
Revenue Growth69.32%
EPS Growth113.55%
CountryIN
Employees1,896
SectorBasic Materials
Sector Strength58
IndustryChemicals - Specialty
Share Statistics
EPS (TTM)4.50
Shares Outstanding113,848,310
10 Day Avg. Volume10,749
30 Day Avg. Volume7,276
Financial Highlights & Ratios
PEG Ratio-3.11
Price to Book (P/B)2.90
Price to Sales (P/S)5.74
P/FCF Ratio-18.80
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)23.2
Revenue Forecast (FY)₹22.11B
Anupam Rasayan India Ltd. Business Overview & Revenue Model
Company Description
Anupam Rasayan India Ltd. engages in the custom synthesis and manufacturing of specialty chemicals in India. The company offers life science related specialty chemicals, such as agro intermediates and agro active ingredients for the agrochemicals ...
How the Company Makes Money
Anupam Rasayan India Ltd. generates revenue through the manufacture and sale of specialty chemicals and intermediates. Its primary revenue streams come from contracts with major players in the agrochemical and pharmaceutical industries, where the ...
Anupam Rasayan India Ltd. Financial Statement Overview
Summary
Income Statement
65
Positive
Balance Sheet
70
Positive
Cash Flow
40
Negative
| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 21.11B | 14.42B | 14.80B | 16.02B | 10.74B | 8.16B |
| Gross Profit | 9.34B | 8.22B | 8.51B | 8.85B | 7.02B | 4.75B |
| EBITDA | 5.19B | 4.00B | 3.82B | 4.29B | 3.03B | 2.02B |
| Net Income | 1.51B | 933.49M | 1.29B | 1.81B | 1.52B | 702.96M |
Balance Sheet | ||||||
| Total Assets | 56.50B | 52.69B | 46.02B | 37.78B | 28.91B | 22.98B |
| Cash, Cash Equivalents and Short-Term Investments | 4.44B | 1.35B | 3.48B | 6.67B | 618.77M | 2.96B |
| Total Debt | 12.23B | 13.73B | 10.70B | 8.22B | 8.36B | 4.23B |
| Total Liabilities | 22.01B | 21.87B | 16.71B | 12.70B | 11.64B | 7.25B |
| Stockholders Equity | 31.97B | 28.50B | 27.61B | 23.73B | 17.27B | 15.73B |
Cash Flow | ||||||
| Free Cash Flow | 3.28B | -4.40B | -6.57B | 713.03M | -3.18B | -1.45B |
| Operating Cash Flow | 5.35B | -301.25M | 590.32M | 2.92B | -1.71B | 14.59M |
| Investing Cash Flow | -2.53B | -3.30B | -3.92B | -5.23B | -4.12B | -1.93B |
| Financing Cash Flow | 182.51M | 2.23B | 3.95B | 3.71B | 3.84B | 4.16B |
Anupam Rasayan India Ltd. Technical Analysis
Negative
1327.70
Price Trends
1263.25
Negative
1258.30
Negative
1187.63
Positive
Market Momentum
-4.55
Negative
48.05
Neutral
62.86
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:ANURAS, the sentiment is Negative. The current price of 1327.7 is above the 20-day moving average (MA) of 1253.23, above the 50-day MA of 1263.25, and above the 200-day MA of 1187.63, indicating a neutral trend. The MACD of -4.55 indicates Negative momentum. The RSI at 48.05 is Neutral, neither overbought nor oversold. The STOCH value of 62.86 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:ANURAS.
Anupam Rasayan India Ltd. Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
69 Neutral | ₹83.94B | 17.09 | ― | 0.67% | 7.53% | 16.26% | |
66 Neutral | ₹59.55B | 30.81 | ― | 1.37% | 4.89% | -8.27% | |
64 Neutral | ₹142.09B | 76.50 | ― | 0.06% | 69.32% | 113.55% | |
64 Neutral | ₹115.77B | 35.11 | ― | 0.15% | 24.25% | 96.45% | |
62 Neutral | ₹67.91B | 48.28 | ― | 0.62% | 3.95% | 8.28% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
61 Neutral | ₹94.41B | 59.25 | ― | 0.74% | 3.80% | 64.94% |
* Basic Materials Sector Average
IN:ANURAS
Anupam Rasayan India Ltd.
1,248.10
541.41
76.61%
IN:ALKYLAMINE
Alkyl Amines Chemicals Limited
1,327.75
-299.82
-18.42%
IN:GARFIBRES
Garware Technical Fibres Limited
599.95
-181.27
-23.20%
IN:JUBLINGREA
Jubilant Ingrevia Ltd.
592.70
-8.68
-1.44%
IN:PRIVISCL
Privi Speciality Chemicals Limited
2,963.60
1,281.02
76.13%
IN:TIMETECHNO
Time Technoplast Limited
170.05
-8.14
-4.57%
Anupam Rasayan India Ltd. Corporate Events
Anupam Rasayan Shareholders Approve Postal Ballot Resolutions via Remote E-Voting
Jan 10, 2026
Anupam Rasayan India Limited has informed the stock exchanges that the resolutions proposed in its postal ballot notice dated December 9, 2025 have been approved by shareholders with the requisite majority through a remote e-voting process conclud...
Anupam Rasayan Closes Trading Window Ahead of December Quarter Results
Dec 27, 2025
Anupam Rasayan India Limited has announced the closure of its trading window for dealing in the company’s securities from January 1, 2026 until 48 hours after the declaration of its unaudited standalone and consolidated financial results for...
Anupam Rasayan Announces Postal Ballot Notice and E-Voting
Nov 23, 2025
Anupam Rasayan India Ltd. has announced the publication of newspaper advertisements regarding a Postal Ballot Notice and remote e-voting for its members. This move is part of the company’s compliance with regulatory requirements, and the adv...
Anupam Rasayan Announces Postal Ballot for Director Appointment
Nov 22, 2025
Anupam Rasayan India Ltd. has announced a postal ballot to seek shareholder approval for the appointment of Mr. Milind Madan Talathi as a Non-Executive Independent Director for a three-year term. This move is part of the company’s strategic ...
Anupam Rasayan Releases Earnings Call Recording for Q2 2025
Oct 18, 2025
Anupam Rasayan India Ltd. announced the availability of the audio recording of its earnings call discussing the unaudited financial results for the quarter and half-year ending September 30, 2025. This announcement, made in compliance with regulat...
Anupam Rasayan Releases Unaudited Financial Results for September 2025
Oct 18, 2025
Anupam Rasayan India Ltd. has announced the publication of its unaudited financial results for the quarter and half year ending September 30, 2025. The results, which are available in both standalone and consolidated formats, have been published i...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.